<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03317535</url>
  </required_header>
  <id_info>
    <org_study_id>2017-10-15</org_study_id>
    <nct_id>NCT03317535</nct_id>
  </id_info>
  <brief_title>Choice of Anesthesia for Endovascular Treatment of Acute Ischemic Stroke in Posterior Circulation</brief_title>
  <acronym>CANVAS-II</acronym>
  <official_title>Choice of Anesthesia for Endovascular Treatment of Acute Ischemic Stroke in Posterior Circulation: a Randomized Controlled Pilot Study (CANVASⅡ)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is few randomized controlled clinical to investigated the impact of anesthetic type on
      outcome in patients with acute ischemic stroke in posterior cerebral circulation. It is
      unknown whether the choice of anesthesia is impacted on the outcomes for these patients or
      not. The investigators will perform a randomized controlled pilot clinical trial of general
      anesthesia versus sedation to explore and find out a potential fact whether anesthetic type
      alters perioperative neurological function in patients with acute ischemic stroke in
      posterior cerebral circulation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>modified rankin score（mRS）</measure>
    <time_frame>post-procedural 90 days</time_frame>
    <description>Modified rankin score（mRS）is used to evaluate the primary outcome. The scale of mRS is 0 to 6. The best neurological outcome is the mRS with 0, indicating no any symptom left, and a good neurological outcome is agreed with a mRS≤2. mRS of 6 is the worst, indicating death. mRS will be evaluated by outcomes assessor who is blinded to the grouping.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Posterior Circulation Brain Infarction</condition>
  <arm_group>
    <arm_group_label>Local anesthesia and sedation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will be injected by dexmedetomidine(adjusted by bispectral index scale ≥70 ) and /or remifentanil（0.01-0.06μg/kg/min）. Patients will maintain spontaneous breathing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will be induced with remifentanil (0.2-0.8 μg/kg), propofol TCI 2-4 ug/ml, and rocuronium (0.6 mg/kg). Anesthesia will then be maintained keep the BIS between 40 and 60. After tracheal intubation, patients will be kept with controlled ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia</intervention_name>
    <description>Patients will be injected with propofol, remifentanil and muscular relaxant with controlled ventilation.</description>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local anesthesia</intervention_name>
    <description>Patients will be injected with Dexmeditomidine and remifentanil.</description>
    <arm_group_label>Local anesthesia and sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spontaneous breath</intervention_name>
    <description>Patients will be kept spontaneous breath.</description>
    <arm_group_label>Local anesthesia and sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Controlled ventilation</intervention_name>
    <description>Patient will be kept with controlled ventilation.</description>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute ischemic stroke in posterior cerebral circulation scheduled to
             receive emergency endovascular treatment; Age between 18-80; The onset time is within
             6 hours; Modified rankin score ≥2 before onset.

        Exclusion Criteria:

          -  Radiological ambiguity concerning infarction and vessel occlusion; Additional
             intracerebral hemorrhage; Anterior circulation infraction; Coma on admission (Glasgow
             coma score less than 8); NIHSS less than 4 or more than 30; Severe agitation or
             seizures on admission; Obvious loss of airway protective reflexes and/or vomiting on
             admission; Being intubated before treatment on admission; Known allergy to anesthetic
             or analgesic;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruquan Han, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruquan Han, M.D., Ph.D.</last_name>
    <phone>8610-67096660</phone>
    <email>ruquan.han@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing TianTan Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruquan Han, M.D., Ph.D</last_name>
      <phone>8610-67096660</phone>
      <email>ruquan.han@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2017</study_first_submitted>
  <study_first_submitted_qc>October 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2017</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Yuming Peng</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Anesthesia Methods</keyword>
  <keyword>Acute Ischemic Stroke</keyword>
  <keyword>Endovascular Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Brain Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

